Questions discussed in this category
Do you generally recommend anti-diarrheals, dietary modifications, or consider this an unacceptable side effect and move to other therapies?
When do you determine SSRI therapy is unsafe to pursue in such situations?
HFE gene mutations in C282Y and H63D are negative.
Should they be placed on routine EGD surveillance and if yes at what intervals?
When it seems fairly certain that this is a drug effect is it something that can just be monitored or requires a change in approach?
If so, what agent(s) do you prefer?
1952319841199021927717674149391346114814110441036385669208
Papers discussed in this category
Blood, 2020 Sep 10
Blood Adv,
J Pharm Pract, 2019 Mar 27
Blood, 2014 Oct 15
Therapeutic drug monitoring, 2022 Jun 01
Pharmacological research, 2016 Aug 10
The Annals of pharmacotherapy, 2018 Aug 06
Am J Gastroenterol,
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 2016 Nov
Journal of hepatology, 2022 Jun 01